Atlas Trials

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

Clinical trial NCT00005606 · COMPLETED

Trial details

NCT number
NCT00005606
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Start date
2000-02-01
Primary completion
2003-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.